Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
1261–1296
Headlines
2939
Sources here
14
Companies here
20
Current section United States Diagnostics & Research news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Labcorp raises earnings outlook on strong medical testing demand

Labcorp has increased its earnings outlook due to strong demand for medical testing. The company's headquarters are located in Burlington, North Carolina. This update was reported by Melos Ambaye from Bloomberg on July 31, 2026.

LH mentioned
Sharemaestro market context Trend signal active 52 weeks +15.6% LH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sotera Health Number of Employees 2026 | Employee Count & Headcount Data

Sotera Health Co. (SHC) had approximately 3,026 employees worldwide as of March 2026, representing a 5.0% growth since 2023. The company, headquartered in Broadview Heights, Ohio, is actively hiring, with 124 job postings in 2026. Sotera Health's workforce is concentrated in North America and …

SHC main company
Sharemaestro market context Trend signal active 52 weeks +15.0% SHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ELAB|PMGC Holdings Inc|Price:0.942|Chg%:+0.062

This article provides a comprehensive stock analysis of PMGC Holdings Inc (ELAB) by TradingKey, highlighting its healthy fundamentals, high growth potential, and "fairly valued" status within the Healthcare Providers & Services industry. It notes low institutional ownership and an expectation for the stock price …

DGX mentioned
Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1% DGX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Guardant Health stock rises after guidance hike (GH:NASDAQ)

Guardant Health (GH) stock rose nearly 10% and hit a new 52-week high after reporting Q2 2026 revenue that significantly beat consensus estimates. The blood-based cancer test maker also raised its full-year outlook, with its oncology portfolio growing 38% year-over-year and screening revenue seeing …

GH main company
Sharemaestro market context Trend signal active 52 weeks +156.0% GH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CLNN|Clene Inc.|Price:5.015|Chg%:-0.025

This article provides a comprehensive stock analysis of Clene Inc. (CLNN) based on TradingKey's Stock Score. It highlights the company's relatively stable fundamentals, high growth potential, and fair valuation within the Biotechnology & Medical Research industry. Despite recent weak market performance, CLNN shows strong …

IQV mentioned
Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6% IQV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Waters Corp. (WAZ) Q1 2026 Earnings Report - Results, Call & Slides

Waters Corp. (WAZ) reported strong Q1 2026 earnings, beating both EPS and revenue expectations. The company also raised its full-year 2026 guidance, citing strong organic growth, successful integration of acquired businesses, and significant synergy achievements. Despite some geographical headwinds, the overall sentiment from the …

WAT main company
Sharemaestro market context Trend signal active 52 weeks +36.4% WAT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Needham raises Veracyte stock price target to $69 on strong Q2 beat

Needham has increased its price target for Veracyte (NASDAQ:VCYT) shares to $69 from $57, maintaining a Buy rating, following the company's strong second-quarter results where revenue and EPS surpassed consensus estimates. Veracyte also raised its 2026 revenue guidance and is noted for its financial …

VCYT main company
Sharemaestro market context Trend signal active 52 weeks +33.1% VCYT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Revvity (NYSE:RVTY) Flaunts Strong Technical Breakout Setup Near 52-Week High

Revvity (NYSE:RVTY) shows a strong technical breakout setup, marked by a high ChartMill Technical Rating of 9/10 and a perfect Setup Quality Rating of 10/10. The stock is consolidating near its 52-week high, with clear support and minimal overhead resistance, presenting an attractive entry …

RVTY main company
Sharemaestro market context Trend signal active 52 weeks +24.4% RVTY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Burning Rock Biotech Ltd (BNR) Financial Health: Profitability & Balance Sheet Analysis

Burning Rock Biotech Ltd (BNR) currently holds a financial score of 7.64, ranking 33 out of 75 in the Healthcare Providers & Services industry, indicating robust financial status but average operating efficiency. The company's latest quarterly revenue decreased by 13.90% year-over-year to $15.94 million, …

BNR main company
Sharemaestro market context Price below Trend Line 52 weeks -5.4% · Next-week setup negative 34.4% BNR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CRVL|CorVel Corp|Price:59.500|Chg%:-2.750

This article provides a comprehensive stock analysis of CorVel Corp (CRVL) by TradingKey, highlighting its strong fundamentals, high growth potential, and fair valuation. The company's revenue has grown consistently, and its net income leads the industry. The analysis also covers institutional ownership, price momentum, …

DGX mentioned
Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1% DGX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Revvity Inc (RVTY) Financial Health: Profitability & Balance Sheet Analysis

Revvity Inc (RVTY) has a stable financial status with a current financial score of 7.36, ranking 83rd in the Healthcare Equipment & Supplies industry. The company reported a 6.97% year-over-year increase in its latest quarterly revenue to $711.12 million, and a 3.60% year-over-year increase …

RVTY main company
Sharemaestro market context Trend signal active 52 weeks +24.4% RVTY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

UNCY|Unicycive Therapeutics Inc|Price:5.285|Chg%:+0.545

This article provides a comprehensive stock analysis of Unicycive Therapeutics Inc (UNCY) by TradingKey, detailing its stock score, financial health, valuation, earnings forecast, price momentum, institutional confidence, and risk assessment. Despite healthy fundamentals and significant growth potential, the stock is considered fairly valued and …

IQV mentioned
Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6% IQV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Veracyte, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:VCYT) 2026-07-31

Veracyte, Inc. (VCYT) published a slide deck for its 2026 Q2 earnings call, reporting earnings per share (EPS) of $0.54, which beat estimates by $0.11. The company's revenue reached $150.32 million, surpassing expectations by $5.84 million and representing a 15.49% year-over-year increase. This presentation …

VCYT main company
Sharemaestro market context Trend signal active 52 weeks +33.1% VCYT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

QGEN|Qiagen NV|Price:41.435|Chg%:-0.375

This article provides a detailed analysis of Qiagen NV (QGEN) stock, highlighting its current market trends, real-time quotes, and related analysis. It covers key financial figures, insights into its growth potential and valuation, and analyst ratings, which currently lean towards "Buy." The company's strengths …

QGEN main company
Sharemaestro market context Price above Trend Line 52 weeks -14.1% QGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Guardant Health, Inc. Stock 12‑Month Price Target Raised to $180.91, Implies 19% Upside

Guardant Health, Inc.'s stock's 12-month average price target has been raised from $174.61 to $180.91, based on estimates from 23 analysts, implying a 19% potential upside from the Jul. 30 closing price. The consensus rating remains "Buy" among 29 covering analysts, with the majority …

GH main company
Sharemaestro market context Trend signal active 52 weeks +156.0% GH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Agilent Number of Employees 2026 | Employee Count & Headcount Data

Agilent Technologies, Inc. has approximately 18,410 employees worldwide as of March 2026, marking a 0.4% growth from 2023. The company is actively hiring with 1,095 job postings in 2026, a 45.4% increase from 2025. Agilent's workforce is concentrated in North America, with an average …

A main company DGX mentioned
Sharemaestro market context Trend signal active 52 weeks +22.8% · Next-week setup negative 44.0% A stored weekly price path from 22 Aug 2025 to 14 Aug 2026

What RadNet (RDNT)'s FDA-Cleared AI Breast Ultrasound Rollout Means For Shareholders

RadNet's subsidiary DeepHealth received FDA clearance for its AI-powered breast ultrasound tool, which will be deployed across RadNet's network for approximately 700,000 annual studies. This move aligns with RadNet's strategy of leveraging AI for improved workflow and scalability in outpatient imaging, although near-term challenges …

RDNT main company
Sharemaestro market context Price above Trend Line 52 weeks +8.9% · Next-week setup positive 55.5% RDNT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amundi Grows Stake in Mettler-Toledo International, Inc. $MTD

Amundi increased its stake in Mettler-Toledo International, Inc. by 44.2% in the first quarter, now owning 171,020 shares worth $215.69 million. Other institutional investors like Norges Bank, M&T Bank Corp, Capital International Investors, Northwestern Mutual Wealth Management Co., and Douglass Winthrop Advisors LLC also …

MTD main company
Sharemaestro market context Price above Trend Line 52 weeks +7.4% · Next-week setup positive 57.4% MTD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amundi Has $190.50 Million Stake in Qiagen N.V. $QGEN

Amundi increased its stake in Qiagen N.V. by 12.4% in the first quarter, now holding 4.76 million shares valued at $190.5 million, representing 2.31% of the company.

QGEN main company
Sharemaestro market context Price above Trend Line 52 weeks -14.1% QGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Key facts: CSTL Q2 Revenue $103.6M; AdvanceAD-Tx 97.8% Concordance

Castle Biosciences (CSTL) reported Q2 revenue of $103.55 million, exceeding estimates of $86.2 million, despite an operating loss of $3.07 million. Additionally, a study revealed that the company's AdvanceAD-Tx testing for atopic dermatitis showed a 97.8% concordance in systemic therapy decisions, significantly higher than …

CSTL main company
Sharemaestro market context Price above Trend Line 52 weeks +42.1% CSTL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context